Quantcast
Last updated on April 19, 2014 at 21:20 EDT

Latest Hologic Inc. Stories

2013-05-06 16:27:13

BEDFORD, Mass., May 6, 2013 /PRNewswire/ -- Hologic, Inc. (Hologic or the Company) (NASDAQ: HOLX), a leading developer, manufacturer and supplier of premium diagnostics products, medical imaging systems and surgical products, with an emphasis on serving the healthcare needs of women, today announced its results for the second fiscal quarter ended March 30, 2013. Highlights of the Quarter Include: Financial: Revenues of $612.7 million, net of a $(6.4) million adjustment related to...

2013-05-02 23:24:23

Nationally recognized, breast center continues commitment to 100% early detection of breast cancer with the addition of breast tomosynthesis. Montclair, NJ (PRWEB) May 02, 2013 Montclair Breast Center is one of the first women´s centers in New Jersey to offer 3D mammography (breast tomosynthesis) for breast cancer screening. Breast tomosynthesis produces a three-dimensional view of the breast tissue that helps radiologists identify and characterize individual breast structures without...

2013-05-01 16:31:16

Addition of tomosynthesis increased breast cancer detection and simultaneously reduced recall rates BEDFORD, Mass., May 1, 2013 /PRNewswire/ -- Hologic, Inc. (Hologic or the Company) (NASDAQ: HOLX), a leading developer, manufacturer and supplier of premium diagnostics products, medical imaging systems and surgical products with an emphasis on serving the healthcare needs of women, today announced the publication of the final results of a large-scale prospective study comparing breast...

2013-04-16 16:24:35

Breast cancer screening with tomosynthesis finds cancers missed by 2D screening alone utilizing the double read with arbitration approach used in many countries of the world BEDFORD, Mass., April 16, 2013 /PRNewswire/ -- Hologic, Inc. (Hologic or the Company) (NASDAQ: HOLX), a leading developer, manufacturer and supplier of premium diagnostics, medical imaging systems and surgical products dedicated to serving the healthcare needs of women, today announced that a new study published...

2013-04-15 08:28:25

DiagnoCure's Board Maintains its Recommendation to Vote for Current Directors QUEBEC CITY, April 15, 2013 /PRNewswire/ - Following the adoption by its Board of directors of an advance notice policy, DiagnoCure Inc. (TSX: CUR)(OTCQX: DGCRF) (the "Corporation") announces that a shareholder has submitted nominations for election as directors of the Corporation at the upcoming Annual and Special meeting of shareholders of April 29, 2013 at which five directors will be elected....

2013-03-26 16:28:23

BEDFORD, Mass., March 26, 2013 /PRNewswire/ -- Hologic, Inc. (Hologic or the Company) (NASDAQ: HOLX), a leading developer, manufacturer and supplier of premium diagnostics products, medical imaging systems and surgical products dedicated to serving the healthcare needs of women, today announced plans to release its second quarter fiscal 2013 operating results on Monday, May 6, 2013, after market close. In conjunction with the release, management will host a conference call on Monday, May 6,...

2013-03-22 20:21:14

BEDFORD, Mass., March 22, 2013 /PRNewswire/ -- Hologic, Inc. (Hologic or the Company) (NASDAQ: HOLX), a leading developer, manufacturer and supplier of premium diagnostics products, medical imaging systems and surgical products dedicated to serving the healthcare needs of women, announced today the expiration of its offer to exchange (the Exchange Offer) up to $1 billion aggregate principal amount of its 6.25% Senior Notes due 2020 which have been registered under the Securities Act of 1933,...

2013-03-22 16:23:47

BEDFORD, Mass., March 22, 2013 /PRNewswire/ -- Hologic, Inc. (Hologic or the Company) (NASDAQ: HOLX), a leading developer, manufacturer and supplier of premium diagnostics, medical imaging systems and surgical products dedicated to serving the healthcare needs of women, today announced that it has successfully completed its sale of the LIFECODES business unit to Immucor, Inc. Hologic has received $85 million in cash (adjusted for working capital items) with the opportunity to earn a...

2013-03-21 16:25:15

Company to highlight groundbreaking 3D technology and other innovations at international breast health conference BEDFORD, Mass., March 21, 2013 /PRNewswire/ -- Hologic, Inc. (Hologic or the Company) (NASDAQ: HOLX), a leading developer, manufacturer and supplier of premium diagnostics products, medical imaging systems and surgical products dedicated to serving the healthcare needs of women, will bring its, "3D Technology: A More Accurate Mammogram " mobile coach tour to the National...

2013-03-19 20:23:23

98% of Providers Interviewed Say They Would Buy 3D Mammography Again BEDFORD, Mass., March 19, 2013 /PRNewswire/ -- Hologic, Inc. (Hologic or the Company) (NASDAQ: HOLX), a leading developer, manufacturer and supplier of premium diagnostics products, medical imaging systems and surgical products dedicated to serving the healthcare needs of women, announced today the results of an independent survey by KLAS Research of Hologic 3D mammography sites in the U.S. The in-depth survey,...